Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

110.12
-1.6700-1.49%
Post-market: 110.120.00000.00%19:30 EDT
Volume:1.05M
Turnover:118.01M
Market Cap:9.16B
PE:-34.28
High:116.20
Open:111.79
Low:109.41
Close:111.79
52wk High:130.05
52wk Low:54.09
Shares:83.15M
Float Shares:66.33M
Volume Ratio:1.41
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2122
EPS(LYR):-3.6900
ROE:-24.15%
ROA:-15.59%
PB:6.07
PE(LYR):-29.84

Loading ...

German Pension Reform Turns Savers into Investors. That Will Fuel the Market. 13D Filings

Dow Jones
·
Jul 03

Kymera Therapeutics (KYMR) Stock Looks Fully Priced After A 405% Run

Simply Wall St.
·
Jul 03

Kymera CFO Bruce Jacobs Sells USD 8.67 Million in Common Shares

Reuters
·
Jul 03

Kymera Therapeutics (KYMR) Is Up 16.7% After KT-621 Trial Acceleration And Index Additions Has The Bull Case Changed?

Simply Wall St.
·
Jul 01

Kymera Therapeutics Director Bruce Booth Reports $57.91 Million Common Share Disposal

Reuters
·
Jul 01

Kymera Therapeutics is Maintained at Buy by B of a Securities

Dow Jones
·
Jun 30

Kymera Therapeutics price target raised to $125 from $110 at BofA

TIPRANKS
·
Jun 30

Kymera Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jun 29

B. Riley Adjusts Kymera Therapeutics Price Target to $155 From $117, Maintains Buy Rating

MT Newswires Live
·
Jun 29

Kymera Therapeutics Inc : Truist Securities Raises Target Price to $136 from $116

THOMSON REUTERS
·
Jun 29

Major Investor Makes Dramatic Move in Kymera Therapeutics Holdings

TIPRANKS
·
Jun 27

BVF Partners Reports Kymera Therapeutics Share Disposal Worth $173.84 Million

Reuters
·
Jun 27

Movement Alert|Kymera Therapeutics Falls 7.48% in Regular Trading, Trading at $107.68

Market Focus
·
Jun 27

Truist Securities Adjusts Kymera Therapeutics PT to $136 From $116, Maintains Buy Rating

MT Newswires Live
·
Jun 26

Kymera Therapeutics price target raised to $129 from $106 at Canaccord

TIPRANKS
·
Jun 26

Kymera Therapeutics Chief Business Officer Noah Goodman Disposes of 5,000 Shares for $570,000

Reuters
·
Jun 26

Sector Update: Healthcare

MT Newswires Live
·
Jun 26

Top Midday Gainers

MT Newswires Live
·
Jun 26

Kymera Therapeutics Price Target Maintained with a $134.00/share by BTIG

Dow Jones
·
Jun 26

Kymera Therapeutics Stock (KYMR) Soars on Accelerated Clinical Trial Enrollment

TIPRANKS
·
Jun 25